Martina Sabatini

Metabolic Reprogramming by 3-Iodothyronamine (T1AM): A New Perspective to Reverse Obesity through Co-Regulation of Sirtuin 4 and 6 Expression

M. Tonelli, G. Chiellini, A. Saba, 2018, International journal of molecular sciences.

Exogenous 3-iodothyronamine rescues the entorhinal cortex from β-amyloid toxicity.

E. Novelli, G. Rutigliano, A. Saba, 2019, Thyroid : official journal of the American Thyroid Association.

Metabolic profiling reveals reprogramming of lipid metabolic pathways in treatment of polycystic ovary syndrome with 3‐iodothyronamine

G. Chiellini, R. Zucchi, M. Rogowski, 2017, Physiological reports.

New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection

F. Biagioni, S. Sestito, S. Rapposelli, 2017, Front. Pharmacol..

Lipolytic Effects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway

S. Rapposelli, S. Rahman, G. Chiellini, 2019, International journal of molecular sciences.

Lipolytic E ff ects of 3-Iodothyronamine (T1AM) and a Novel Thyronamine-Like Analog SG-2 through the AMPK Pathway

G. Chiellini, M. Rogowski, L. Bellusci, 2022 .

Design, Synthesis, and Evaluation of Thyronamine Analogues as Novel Potent Mouse Trace Amine Associated Receptor 1 (mTAAR1) Agonists.

R. Gainetdinov, P. Fossa, E. Cichero, 2015, Journal of medicinal chemistry.

Synthesis and Biological Evaluation of Cyclopropylamine Vitamin D‐Like CYP24A1 Inhibitors

H. DeLuca, G. Nesi, S. Sestito, 2017 .

Effect of Hypothyroidism and Hyperthyroidism on Tissue Thyroid Hormone Concentrations in Rat

M. Nannipieri, A. Saba, D. Colligiani, 2016, European Thyroid Journal.